# Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

> **NCT00209222** · PHASE3 · UNKNOWN · sponsor: **European Mantle Cell Lymphoma Network** · enrollment: 360 (estimated)

## Conditions studied

- Lymphoma, Mantle-Cell

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin
- **DRUG:** Vincristine
- **DRUG:** Prednisone
- **DRUG:** Cisplatinum
- **DRUG:** Ara-C
- **DRUG:** Dexamethasone
- **DRUG:** BCNU
- **DRUG:** Melphalan
- **DRUG:** Etoposide
- **DRUG:** G-CSF
- **PROCEDURE:** chemotherapy: R-CHOP
- **PROCEDURE:** chemotherapy: R-DHAP
- **PROCEDURE:** chemotherapy: Dexa-BEAM
- **PROCEDURE:** stem cell harvest
- **PROCEDURE:** total body irradiation
- **PROCEDURE:** high-dose chemotherapy: Cyclophosphamide
- **PROCEDURE:** high-dose chemotherapy: Ara-C /Melphalan

## Key facts

- **NCT ID:** NCT00209222
- **Lead sponsor:** European Mantle Cell Lymphoma Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209222, "Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00209222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*